MNOV MediciNova, Inc.
-
MediciNova Reported In-line with Estimates
Thursday, November 12, 2026 · 12:00 AM ET
MediciNova (MNOV) reported a loss of $0.06 per share on revenue of $0.14 million for the third quarter ended September 2026. The consensus estimate was a loss of $0.06 per share on revenue of $0.15 million. The company reported in-line with consensus estimates while revenue grew 13.01% on a year-over-year basis.
MediciNova Inc is a development stage biopharmaceutical company. It is engaged in acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($0.06)
Earnings Whisper®
—
Consensus Estimate
($0.06)
Earnings Surprise
Earnings Growth
Reported Revenue
$0.14M
Revenue Estimate
$0.15M
Revenue Surprise
Revenue Growth